Class Central is learner-supported. When you buy through links on our site, we may earn an affiliate commission.

University of Buckingham

Molecular Tumor Board 2024-25

University of Buckingham via Coursera

Go to class Write review

Overview

Coursera Flash Sale
40% Off Coursera Plus for 3 Months!
Grab it
Se trata de un curso que nace a raíz de una de las sesiones formativas que realiza cada 15 días el Servicio de Oncología Médica del Hospital Clínic de Barcelona (HCB). En este curso se presentan casos clínicos simulando un MTB de tumores sólidos, con un objetivo principal, mejorar el conocimiento específico del impacto clínico del perfil molecular en tumores sólidos. Está destinado a médicos oncólogos y a estudiantes y profesionales vinculados a la oncología médica. Cada seminario que conforma el curso lo presenta un profesional de una patología diferente del Servicio de Oncología Médica del HCB.

Syllabus

  • Chasing a FGFR inhibitor by Dra. Laura Ferrer
  • Meeting desmoplastic melanoma by Dr. Roberto Martín
    • Melanoma Cancer
  • BRAF fusions in low grade gliomas by Dr. Manuel Mazariegos
    • SNC Tumor
  • Re-defining the mutational landscape of pancreatic cancer by Dra. Lina Candia
    • Upper GI tumor
  • Targeting drivers in a non-smoker female by Dra. Laia Fernández
    • Lung Cancer
  • The complex interplay of estrogenic pathway resistance by Dr. Benjamin Vicente Walbaum García
    • Breast Cancer
  • Integrating molecular results in HR_HER2 mBC in the daily practices by Dra. Olga Martínez
    • Breast Cancer
  • Precision medicine in pancreatic cancer by Dra. Laura González
    • Colorectal Cancer
  • METing cancer susceptibility in NSCLC by Dr. Juan Carlos Laguna
    • Lung Cancer
  • Endometrial cancer_entering the inmunotherapy era by Dr. Javi Muñoz
    • Gynaecological Cancer
  • Drugging KRAS in lung cancer by Dr. Alejandro Navarro
    • Lung Cancer
  • A long responder GBM case by Dra. Carlota Rubio
  • Precision Medicine in Colorrectal cancer by Dra. Mariam Stephanie Rojas
    • Colorectal Cancer
  • Metastatic BRCAmut TNBC with early relapse after neo/adjuvant therapy. Is there a rationale for a cell therapy approach? by Dr. Víctor Albarrán
    • Inmunoncology
  • Exploring new biomarkers in the treatment of advanced ovarian cancer by Dra. Lydia Gaba
    • Gynaecological Cancer
  • Fighting against the lack of molecular targets in renal cancer by Dra. Laia Fernández
  • Precision Medicine in Gastric Cancer: Expectations vs. Reality by Dr. Ismael Macías
    • Upper GI tumor

Taught by

Mercè Moreda, Dr. Aleix Prat Aparicio, Dra. Laura Mezquita Perez, and Eva Paradell Salinas

Tags

Reviews

Start your review of Molecular Tumor Board 2024-25

Go to class

Never Stop Learning.

Get personalized course recommendations, track subjects and courses with reminders, and more.

Sign up for free
Someone learning on their laptop while sitting on the floor.